garadacimab
General
Pronunciation:
gair-ah-das-i-mab
Trade Name(s)
- Andembry
Ther. Class.
antiangioedema agents
Pharm. Class.
monoclonal antibodies
temporary class
factor XII inhibitorThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Garadacimab." Davis's Drug Guide Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580196/all/garadacimab.
Vallerand AHA, Sanoski CAC. Garadacimab. Davis's Drug Guide Davis's Drug Guide. F.A. Davis Company; 2026. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580196/all/garadacimab. Accessed October 12, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Garadacimab. In Davis's Drug Guide Davis's Drug Guide (20th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580196/all/garadacimab
Vallerand AHA, Sanoski CAC. Garadacimab [Internet]. In: Davis's Drug Guide Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 October 12]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580196/all/garadacimab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - garadacimab
ID - 3580196
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580196/all/garadacimab
PB - F.A. Davis Company
ET - 20
DB - Pediatrics Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

